Nadine Rouphael and Mark Prausnitz discuss the findings from their phase 1 trial that uses a dissolvable microneedle patch to deliver an influenza vaccine to patients.
Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv
